Optic nerve crush: Axonal responses in wild-type and bcl-2 transgenic mice

被引:0
|
作者
Chierzi, S
Strettoi, E
Cenni, MC
Maffei, L
机构
[1] CNR, Ist Neurofisiol, I-56127 Pisa, Italy
[2] Scuola Normale Super Pisa, I-56127 Pisa, Italy
来源
JOURNAL OF NEUROSCIENCE | 1999年 / 19卷 / 19期
关键词
survival; axotomy; regeneration; sprouting; bcl-2; myelin;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Retinal ganglion cells of transgenic mice overexpressing the anti-apoptotic protein Bcl-2 in neurons show a dramatic increase of survival rate after axotomy. We used this experimental system to test the regenerative potentials of central neurons after reduction of nonpermissive environmental factors. Survival of retinal ganglion cells 1 month after intracranial crush of the optic nerve was found to be 100% in adult bcl-2 mice and 44% in matched wild-type (wt) mice. In the optic nerve, and particularly at the crush site, fibers regrowing spontaneously or simply sprouting were absent in both wt and bcl-2 mice. We attempted to stimulate regeneration implanting in the crushed nerves hybridoma cells secreting antibodies that neutralize central myelin proteins, shown to inhibit regeneration (IN-1 antibodies) (Caroni and Schwab, 1988). Again, we found that regeneration of fibers beyond the site of crush was virtually absent in the optic nerves of both wt and bcl-2 mice. However, in bcl-2 animals treated with IN-1 antibodies, fibers showed sprouting in the proximity of the hybridoma implant. These results suggest that neurons overexpressing bcl-2 are capable of surviving axotomy and sprout when faced with an environment in which inhibition of regeneration has been reduced. Nevertheless, extensive regeneration does not occur, possibly because other factors act by preventing it.
引用
收藏
页码:8367 / 8376
页数:10
相关论文
共 50 条
  • [21] Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2
    Adams, ML
    Pierce, RH
    Vail, ME
    White, CC
    Tonge, RP
    Kavanagh, TJ
    Fausto, N
    Nelson, SD
    Bruschi, SA
    MOLECULAR PHARMACOLOGY, 2001, 60 (05) : 907 - 915
  • [22] The daily rhythm of amyloid beta peptide in wild-type and transgenic mice
    Buzinova, Valeria
    Johnson, Carrie
    Turton, Savannah
    Barth, Sarah
    Padgett, Samantha
    Kohler, Katharina
    Whitlock, Haleigh
    Duncan, Marilyn
    Murphy, Michael
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S714 - S714
  • [23] CNTF PREVENTS AXONAL INJURY FROM SCIATIC-NERVE CRUSH IN CTNF-OVERPRODUCING TRANSGENIC MICE
    BIERI, PL
    APFEL, S
    SAOTOME, Y
    HIRSCH, D
    AREZZO, J
    KESSLER, J
    NEUROLOGY, 1995, 45 (04) : A336 - A336
  • [24] Transcriptional responses to ischemia in A1AR transgenic and wild-type hearts
    Ashton, K
    Holmgren, K
    Grimmond, S
    Matherne, P
    Headrick, J
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A6 - A6
  • [25] Frequent expression of bcl-2 in renal-cell carcinomas carrying wild-type p53
    Tomita, Y
    Bilim, V
    Kawasaki, T
    Takahashi, K
    Okan, I
    Magnusson, KP
    Wiman, KG
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (03) : 322 - 325
  • [26] The effect of Bcl-2 overexpression on corneal epithelial homeostasis in transgenic mice
    Ladage, PM
    Robertson, DM
    Yamamoto, T
    Petroll, WM
    Jester, JV
    Cavanagh, HD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U325 - U325
  • [27] Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice.
    Lacombe, C
    Lacronique, V
    Varlet, P
    Mayeux, P
    Porteu, A
    Kahn, A
    Gisselbrecht, S
    BLOOD, 1997, 90 (10) : 223 - 223
  • [28] The origin of anti-nuclear antibodies in bcl-2 transgenic mice
    Mandik-Nayak, L
    Nayak, S
    Sokol, C
    Eaton-Bassiri, A
    Madaio, MP
    Caton, AJ
    Erikson, J
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (03) : 353 - 364
  • [29] Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice
    Richfield, EK
    Thiruchelvam, MJ
    Cory-Slechta, DA
    Wuertzer, C
    Gainetdinov, RR
    Caron, MG
    Di Monte, DA
    Federoff, HJ
    EXPERIMENTAL NEUROLOGY, 2002, 175 (01) : 35 - 48
  • [30] BCL-2 TRANSGENIC LPR MICE SHOW PROFOUND ENHANCEMENT OF LYMPHADENOPATHY
    REAP, EA
    FELIX, NJ
    WOLTHUSEN, PA
    KOTZIN, BL
    COHEN, PL
    EISENBERG, RA
    JOURNAL OF IMMUNOLOGY, 1995, 155 (11): : 5455 - 5462